Yoga and Aerobic Exercise Training in Primary Dysmenorrhea
Comparison of the Effects of Yoga and Aerobic Exercise Training in Primary Dysmenorrhea
1 other identifier
interventional
44
1 country
1
Brief Summary
The aim of this study is to compare the effects of aerobic exercise and yoga exercises on menstrual pain parameters (pain severity and duration, analgesic usage), uterine artery blood flow, menstrual stress level, physical fitness, anxiety/depressive symptom level, quality of life and sleep quality in individuals with primary dysmenorrhea. This study is a prospective, parallel group, randomized study. Three days a week for eight weeks, the participants in this study will receive individualized yoga and aerobic exercise. In the literature, there are no studies comparing the effectiveness of aerobic exercise and yoga in the management of PD, which is a public health problem that seriously affects women's lives. Especially when aerobic exercise and yoga exercises are considered, there is no study on how much the features such as uterine artery blood flow and physical fitness sub-parameters have changed with these two commonly used exercise types separately in the management of PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2022
CompletedStudy Start
First participant enrolled
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
November 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2023
CompletedNovember 15, 2024
November 1, 2024
10 months
October 31, 2022
November 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Menstrual pain severity
As primary outcome measures, the highest menstrual pain severity perceived by the participants in their last menstruation and the average of the pain severity in the first 3 days of their menstruation will be evaluated. A 10-cm VAS from zero (no pain at all) to 10 (the worst pain I have ever felt) will be used to determine the severity of menstrual pain. Individuals will be asked to mark the severity of pain they felt in the first 3 days of their last menstruation on 3 separate VAS lines.
Change in severity of menstrual pain from baseline up to end of 8th week, 3rd month, and 6th month.
Secondary Outcomes (17)
Uterine artery blood flow
Change in uterine artery blood flow from baseline up to end of 8th week.
Body mass index
Change in body mass index from baseline up to end of 8th week, 3rd month, and 6th month.
body fat percentage
Change in body fat percentage from baseline up to end of 8th week, 3rd month, and 6th month.
body fat amount
Change in body fat amount from baseline up to end of 8th week, 3rd month, and 6th month.
lean body weight ratio
Change in lean body weight ratio from baseline up to end of 8th week, 3rd month, and 6th month.
- +12 more secondary outcomes
Study Arms (2)
Aerobic Exercise
EXPERIMENTALAerobic exercise group with 8 weeks of individualized exercise according to the Karvonen protocol (heart rate reserve percentage-% HR). Exercise training will be 30 minutes at 50% of HR between weeks 0-2, 45 minutes at 50% of HR between weeks 2-4, 45 minutes at 60% of HR between weeks 4-6 and 6-8 weeks It will be done on the treadmill 3 days a week, for 60 minutes at 60% of HR between weeks. The treadmill speed will be adjusted during exercise to maintain the set target heart rate level.
Yoga Exercise
ACTIVE COMPARATORYoga exercise group with 8 weeks of individualized exercise program. Exercise training will be done 3 days a week. The duration of the exercise will be adjusted to be the same as the aerobic exercise group.
Interventions
Individuals in this group will be given 8-week individualized exercise according to the Karvonen protocol (heart rate reserve percentage-% HR). Exercise training will be 30 minutes at 50% of HR between weeks 0-2, 45 minutes at 50% of HR between weeks 2-4, 45 minutes at 60% of HR between weeks 4-6 and 6-8 weeks It will be done on the treadmill 3 days a week, for 60 minutes at 60% of HR between weeks. The treadmill speed will be adjusted during exercise to maintain the set target heart rate level.
Individuals in this group will be given 8-week individualized yoga exercise including stretching, relaxing, strength training. Exercise training will be done 3 days a week. The duration of the exercise will be adjusted to be the same as the aerobic exercise group.
Eligibility Criteria
You may qualify if:
- Individuals who do not have any known disease (systemic, metabolic, etc.),
- No complaints of acute or chronic pain other than dysmenorrhea,
- Meeting the primary dysmenorrhea criteria outlined in the Primary Dysmenorrhea Consensus Guide (onset of menstrual pain 6-24 months after menarche, menstrual pain lasting 8-72 hours, and the most severe pain felt on the 1st or 2nd day of menstruation),
- Have a regular menstrual cycle (28± 7 days),
- The severity of menstrual pain in the last 6 months is ≥ 4 cm according to the Visual Analogue Scale,
- years and over,
- Nulligravid (unborn)
- Volunteer female individuals who gave consent to participate in the study
You may not qualify if:
- Individuals undergoing pelvic surgery,
- Having a history and/or finding of secondary dysmenorrhea,
- Receiving alternative treatment,
- Using intrauterine contraceptive device or birth control pill,
- Individuals with situations where exercise is contraindicated (answering yes to any of the 7 questions on the exercise readiness scale),
- Not complying with the requirements of the research protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gamze Nalan Çinar
Ankara, 06100, Turkey (Türkiye)
Related Publications (9)
Wickstrom K, Edelstam G. Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis. Sex Reprod Healthc. 2017 Oct;13:35-40. doi: 10.1016/j.srhc.2017.05.004. Epub 2017 May 25.
PMID: 28844356BACKGROUNDEnright PL. The six-minute walk test. Respir Care. 2003 Aug;48(8):783-5.
PMID: 12890299BACKGROUNDGuimaraes AC, Vaz MA, De Campos MI, Marantes R. The contribution of the rectus abdominis and rectus femoris in twelve selected abdominal exercises. An electromyographic study. J Sports Med Phys Fitness. 1991 Jun;31(2):222-30.
PMID: 1836517BACKGROUNDBianco A, Lupo C, Alesi M, Spina S, Raccuglia M, Thomas E, Paoli A, Palma A. The sit up test to exhaustion as a test for muscular endurance evaluation. Springerplus. 2015 Jul 2;4:309. doi: 10.1186/s40064-015-1023-6. eCollection 2015.
PMID: 26155448BACKGROUNDArnold CM, Warkentin KD, Chilibeck PD, Magnus CR. The reliability and validity of handheld dynamometry for the measurement of lower-extremity muscle strength in older adults. J Strength Cond Res. 2010 Mar;24(3):815-24. doi: 10.1519/JSC.0b013e3181aa36b8.
PMID: 19661831BACKGROUNDMoos RH. The development of a menstrual distress questionnaire. Psychosom Med. 1968 Nov-Dec;30(6):853-67. doi: 10.1097/00006842-196811000-00006. No abstract available.
PMID: 5749738BACKGROUNDLovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43. doi: 10.1016/0005-7967(94)00075-u.
PMID: 7726811BACKGROUNDLevine DW, Kripke DF, Kaplan RM, Lewis MA, Naughton MJ, Bowen DJ, Shumaker SA. Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003 Jun;15(2):137-48. doi: 10.1037/1040-3590.15.2.137.
PMID: 12847774BACKGROUNDJaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989 Dec;10(4):407-15. doi: 10.1016/0197-2456(89)90005-6.
PMID: 2691207BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serap Özgül, Prof
Hacettepe University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
October 31, 2022
First Posted
November 21, 2022
Study Start
October 31, 2022
Primary Completion
September 1, 2023
Study Completion
December 4, 2023
Last Updated
November 15, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share